Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
250 participants
OBSERVATIONAL
2022-03-15
2024-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ramadan Fasting Effects in Patients With Cardiovascular Risk Factors
NCT02720133
Effect of Intermittent Fasting (Month of Ramadan) on Health
NCT05571891
Physiological and Sensory Responses to Prolonged Fasting in Humans
NCT05977569
Monday is Fasting Day - Non-Randomized Trial on Intermittent Fasting
NCT02253056
A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases
NCT03193177
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. The week before Ramadan (Pre-R).
2. the last week of Ramadan (R).
3. the last week of the month following Ramadan (Post-R). Participants that miss one appointement or more are exluded from the study. Patient recrutement is conducted in primary care centers of the state of Monastir, out-patients clinic (Cardiology, Endocrinology) at the emergency department of Fattouma Bourguiba university hospital after a clarified written consent.
All patients benifit of an endothelial peripheral arterial tonometry (Endo-PAT) test .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
participents who has the intention to fast Ramadan
subjects with at least two cardiovascular risk factors according to Framingham classification or with out any risk .
Reactive hyperemia-peripheral arterial tonometry Index (RHI )
RHI was assessed by RH-PAT using the EndoPAT2000 system .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reactive hyperemia-peripheral arterial tonometry Index (RHI )
RHI was assessed by RH-PAT using the EndoPAT2000 system .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Hemodynamic instability.
* Myocardial infarction requiring urgent revascularization.
* Parkinsonism: tremor problem.
* Refusal, communication problem.
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Monastir
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pr. Semir Nouira
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Semir Nouira, Professor
Role: PRINCIPAL_INVESTIGATOR
University of Monastir
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital Fattouma Bourguiba
Monastir, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RHIFasting
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.